Raman Bhaumik
Raman Bhaumik | |
|---|---|
 | |
| Occupation | Pharmacy, healthcare |
| Website | texasstarpharmacy |
Raman Bhaumik is a healthcare leader with experience in operations, pharmaceuticals, and healthcare. She is an owner and current Chief People Officer of Texas Star Pharmacy.
Education and Career
Raman Bhaumik is a licensed pharmacist in multiple states.[1] Her work focuses on enhancing patient care and ensuring operational efficiency.[2] Additionally, she completed advanced leadership training.[3]
Raman Bhaumik is the current Chief People Officer of Texas Star Pharmacy in Plano, Texas, which specializes in customized compounding solutions and personalized patient care.[4] The regional pharmacy serves clientele across Texas and several other states.[5] As part of her role, Bhaumik is responsible for employee well-being, talent retention, and leadership development.
Bhaumik has worked for Texas Star since 2018.[6] The pharmacy was placed on the “Top 100 Fastest Growing Healthcare Companies in the Country” according to Inc. Magazine and “Top 10 Compounding Pharmacies” lists according to Healthcare Business Review.[3][7]
Additional Activities
Raman Bhaumik is based in Dallas, Texas.[8] Raman Bhaumik has interests in community service, hiking, and reading.[3] She mentors aspiring pharmacists and future healthcare leaders.[2]
References
- ↑ Bhaumik, Raman. "About Raman Bhaumik". Medium. Retrieved 1 May 2025.
- ↑ 2.0 2.1 "Raman Bhaumik". ramanbhaumik.com. Retrieved 1 May 2025.
- ↑ 3.0 3.1 3.2 "Our Team". Texas Star Pharmacy. Retrieved 1 May 2025.
- ↑ "Jay Bhaumik and Texas Star Pharmacy to Showcase Innovation at LongevityFest 2024". ABC4. EIN Presswire. 22 March 2024. Retrieved 1 May 2025.
- ↑ "Texas Star Pharmacy". Healthcare Business Review. Retrieved 1 May 2025.
- ↑ Bhaumik, Jay. "Jay Bhaumik". LinkedIn. Retrieved 1 May 2025.
- ↑ "Top Compounding Pharmacy Services Companies 2023". Healthcare Business Review. Retrieved 1 May 2025.
- ↑ "Raman Bhaumik - Crunchbase Person Profile". Crunchbase. Retrieved 1 May 2025.